Cognitive Tests – Contextual Fear Conditioning
The contextual fear conditioning test is a powerful behavioral test used to study associative learning and memory retention
Key Research Model Applications of Contextual Fear Conditioning
In contextual fear conditioning, mice learn to pair an unconditioned context with an aversive context. The freezing response of the mouse is monitored to assess the extent to which the unconditioned stimulus is paired with the aversive context. By capitalizing on the natural freezing response to fear, this test evaluates the ability of rodents to associate a specific context with an aversive stimulus, such as a mild foot shock. This test is a measure of both anxiety and cognition (learning and memory). Reach out to our scientific experts to discuss how you can integrate contextual fear conditioning into your research.
Mouse Behavioral Testing Made Simple.
Explore our extensive portfolio of validated and tailored behavioral and cognitive rodent tests designed to advance your research.
Contextual Fear Conditioning Sample Data
A fear conditioning box is used to measure contextual fear learning and memory.
The Fear conditioning test consists of 2 days. The first day (training), mice receive 1 mild electrical foot shock that is connected with a background condition (noise, scent). Day after receiving a mild electrical shock, mice are placed in the same box for 180 seconds and freezing duration is measured. Freezing duration is used as a measure of intact learning and memory performance.
A fear conditioning box is used to measure contextual fear learning and memory.
Stxbp1 +/- mice mimic cognitive impairments observed in epileptic patients that can be detected during a fear conditioning assay.
A fear conditioning box is used to measure contextual fear learning and memory.
WT mice spend on average more time freezing than Fmr1 KO mice, confirming that Fmr1 KO mice have a deficiency in recalling contextual fear memory (P=0.01).
The People Behind Your Research
Thomas Vogels, PhD, In Vivo Neurology Study Director
Leads an expert team of scientists with vast experience in our Neurology models to help you choose the right model and guide your optimal study design. We provide the solution to accelerating your drug development.
Stay Curious: More Articles to Explore
MDX Mouse Model Validation Data
This month we’re highlighting one of the most commonly used mouse models to study Duchenne Muscular Dystrophy (DMD) – the MDX mouse model B10.mdx), and explore how our advanced services can support your efficacy studies in DMD. The X-linked muscular dystrophy (MDX)...
InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
Researchers will benefit from InnoSer’s preclinical drug development expertise combined with Hasselt University’s foundational knowledge in Multiple Sclerosis (MS) to advance preclinical MS research. Diepenbeek, Belgium, October 16th, 2024 — InnoSer, a leading...
Introduction to InnoSer’s Preclinical Epilepsy Research CRO Platform
Preclinical epilepsy-related research with InnoSer Broadly speaking, epilepsy is a large spectrum of distinct epileptic syndromes that differ in their etiologies, mechanisms, pathophysiological processes, associated comorbidities, and response profile to available...
Phenotyping of a C3-PMP22 mouse model of CMT1A
Charcot-Marie Tooth (CMT) disease is a hereditary, demyelinating peripheral neuropathy, leading to progressive muscle atrophy, weakness and subsequent walking disabilities and sensory impairments. Charcot-Marie Tooth Type 1A (CMT1A) is the most common type of CMT,...
AAALAC Accreditation
InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.
Animal Welfare
The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.
info@innoserlaboratories.com